Dabur India Limited
Records under this name other than patents Dabur India Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Dabur India Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,838,569 | Process for preparation of paclitaxel trihydrate and docetaxel trihydrate Formerly held Term ended Term ended Apr 22, 2023 · From the USPTO record | Term ended | Term ended Apr 22, 2023 | From the USPTO record |
| US D574,710 | Hair cream container Term ended Term ended Aug 12, 2022 · From the USPTO record | Term ended | Term ended Aug 12, 2022 | From the USPTO record |
| US 6,900,342 | Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof Formerly held Lapsed on the fee record Ended May 31, 2017 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2017 | From the USPTO record |
| US 7,247,738 | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids Formerly held Lapsed on the fee record Ended Jul 24, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2015 | From the USPTO record |
| US 6,506,905 | Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid Formerly held Lapsed on the fee record Ended Jan 14, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2015 | From the USPTO record |
| US 7,759,494 | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxy-carbonyl]-5-oxazolidine carboxylic acids Formerly held Lapsed on the fee record Ended Jul 20, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 20, 2014 | From the USPTO record |
| US 6,891,050 | Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs Formerly held Lapsed on the fee record Ended May 10, 2013 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2013 | From the USPTO record |
| US 6,881,852 | Process of purification of paclitaxel and docetaxel Formerly held Lapsed on the fee record Ended Apr 19, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2013 | From the USPTO record |
| US 6,599,541 | Composition for treatment of drug resistant bacterial infections and a method of treating drug resistant bacterial infections Lapsed on the fee record Ended Jul 29, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2011 | From the USPTO record |